January | View Newsletter

February | View Newsletter

March | View Newsletter

Includes:

• President’s Message: Taking Action in 2007

• Feb Conf Call: "Intimacy & Prostate Cancer"

• Companies, Chapters Signing Up for Sneakers@Work Day

• New Tests of Dendreon’s Prostate Cancer

• Doc Moyad’s What Works and What is Worthless Column: Vitamin D—Part II

• Read more..

Includes:

• President’s Message: “What Is Awareness?

• Special Thanks to Joe Piper

• The Year in Prostate Cancer: Part I of II

• Doc Moyad’s What Works and What is Worthless Column: Vitamin D—Part III

• Feb. 13th Conference Call:
  Intimacy & Prostate Cancer

• 2nd Annual Us TOO Online Auction
  Announced, Seeking Donated Items for Bid

• Read more..

Includes:

• Survivor Rate Highest with Prostatectomy for Localized Prostate Cancer

• New Members for Us TOO Board of Directors

• The Year in Prostate Cancer, Part II

• Medicare Part D and Erectile Dysfunction

• Leading by Example

• PROVENGE^® Granted FDA Priority Review

• Read more..

April | View Newsletter

MAY | View Newsletter

June | View Newsletter

Includes:

• Special Burning Issues Supplement: Highlights from the 2007 Multidisciplinary Prostate Cancer Symposium - February 21-24, 2007, Orlando, FL

• GPC Biotech Provides Satraplatin for Free

• Calcitriol with Docetaxel Boosts Survival

• The Year in Prostate Cancer - Part 3

• Estrogen Therapy: DES (Diethylstilbestrol)

• Doc Moyad’s What Works and What is Worthless Column: Zinc supplementation?

• Read more..

Includes:

• Special Burning Issues Supplement: Prostate cancer and incontinence: coping strategies and treatment options

• MRI in Managing Prostate Cancer

• FDA Panel Backs New Prostate Vaccine

• Adjuvant ADT Can “Cure” Nonmetastasized Prostate Cancer

• Alendronate Increases BMD in Prostate Cancer Patients Receiving ADT

• Doc Moyad’s What Works and What is Worthless Column—Lycopene

• Read more..

Includes:

• Doc Moyad’s What Works and What is Worthless Column—Provenge®

• Cell Genesis Reports Phase II Results with GVAX Immunotherapy

• A Survivor Reviews the 2007 ASCO Prostate Cancer Symposium

• UCSD Researchers Report Ability to Detect Cancer at Earliest, Curable Stage

• New Blood Test for Prostate Cancer—Can EPCA-2 be on the Horizon?

• Possible New Cancer Treatment? Antifungal Drug Stops Blood Vessel Growth

• Read more..

July | View Newsletter

Includes:

• New AUA Prostate Cancer Guidelines

• FDA Requirements for Provenge^® Licensure

• Consider Source of Localized Prostate Cancer Recommendations

• Dendreon Sued after Provenge’s Ok Put Off

• ²²³Radium in Hormone-Refractory Cancer

• Update:Outcomes with Primary Therapy for Intermediate Risk Prostate Cancer

• Read more..

• New Data from ASCO on SPARC Trial

• Us TOO University in Austin, Texas “A Marvelous Evening”

• Survivorship Care Plan Is an Important Part of Cancer Care

• Sneakers@ Work Day, Great Fun, Great Success

• F-18 Fluor Choline PET/CT Assesses Bone Metastases in Prostate Cancer

• New Procedure Minimizes Post-Prostatectomy Incontinence

• Read more..

• Court Sees No Right to Unapproved Drugs

• FDA Requests More Data on Satraplatin

• Hormone Inhibitor Promising For Hard-to-Treat Prostate Cancer

• FDA Sued Over Provenge Delay

• Botox for Treating Prostate Problems

• Doc Moyad’s “No Bogus Science” Column

• Friday the 13th Lucky for Prostate Pointers

• Read more..

October | View Newsletter

November | View Newsletter

December | View Newsletter

Includes:

• CMS Proposal Would Virtually Eliminate Medicare Clinical Trials Coverage

• Statins Fail to Cut the Androgens that Fuel Prostate Cancer

• Stress Management before Prostatectomy

• First Biomarker Discovered that Predicts Prostate Cancer Outcome

• Prostate Px® Test Results Published

• Doc Moyad’s What Works and What is Worthless Column

• Read more..

Includes:

• Charity Navigator Gives Us TOO 4-Star Rating

• Gleason Score and Prostate Cancer Prognosis

• New Study Refutes Belief that Black Men Have More Aggressive Prostate Cancer

• Us TOO Reaches Out to Federal Employees and Military

• Nomogram Can Predict Life Expectancy

• oc Moyad’s What Works and What is Worthless Column—Ginseng

• Read more..

Includes:

• Us TOO’s 2006 Annual Report Now Available

• New Free Kits for Newly-Diagnosed Men

• Survival Analysis from the SPARC Trial

• Us TOO University Chicago Program a Success

• October 30th Intimacy Teleconference a Success

• Biopsy Site Affects Prostate Cancer Detection

• Read more..